Considering that Pirfenidone is metabolised in the CYP1A2 enzyme pathway, any drug which inhibits this enzyme is likely to precipitate the toxicity of pirfenidone: concomitant therapy is usually to be prevented. The knowledge that coagulation factors are overexpressed inside the fibrotic lung has led on the belief that anticoagulation might https://seymourq887blw9.wikilowdown.com/user